At #CaringForRare2026, one message was clear: progress in rare diseases happens when researchers, clinicians and patients work together.
CTGCT's Gregor Cuzak joined discussions to advance gene & cell therapies.
Read more: ctgct.si/en/objave/ct...
#RareDiseases #GeneTherapy #CellTherapy #CTGCT
CTGCT's Gregor Cuzak joined discussions to advance gene & cell therapies.
Read more: ctgct.si/en/objave/ct...
#RareDiseases #GeneTherapy #CellTherapy #CTGCT
CTGCT at the Caring for Rare 2026 Conference: In Rare Diseases, Research, Clinical Practice and Patients Need a Shared Space - CTGCT
A representative of CTGCT – the Centre of Excellence for Technologies of Gene and Cell Therapy, Gregor Cuzak, attended the 7th regional Caring for Rare 2026 conference in Belgrade on 3 and 4 September...
ctgct.si
September 29, 2026 at 8:07 AM
At #CaringForRare2026, one message was clear: progress in rare diseases happens when researchers, clinicians and patients work together.
CTGCT's Gregor Cuzak joined discussions to advance gene & cell therapies.
Read more: ctgct.si/en/objave/ct...
#RareDiseases #GeneTherapy #CellTherapy #CTGCT
CTGCT's Gregor Cuzak joined discussions to advance gene & cell therapies.
Read more: ctgct.si/en/objave/ct...
#RareDiseases #GeneTherapy #CellTherapy #CTGCT
Another confirmed speaker for #CTGCTDay2026!
We’re pleased to welcome Jan Procházka from the Czech Centre for Phenogenomics, whose work spans functional genomics, rare genetic diseases & preclinical research.
✅ Submit your abstract
✅ Register to attend
Link: ctgct.si/en/ctgct-day...
We’re pleased to welcome Jan Procházka from the Czech Centre for Phenogenomics, whose work spans functional genomics, rare genetic diseases & preclinical research.
✅ Submit your abstract
✅ Register to attend
Link: ctgct.si/en/ctgct-day...
September 21, 2026 at 1:42 PM
Another confirmed speaker for #CTGCTDay2026!
We’re pleased to welcome Jan Procházka from the Czech Centre for Phenogenomics, whose work spans functional genomics, rare genetic diseases & preclinical research.
✅ Submit your abstract
✅ Register to attend
Link: ctgct.si/en/ctgct-day...
We’re pleased to welcome Jan Procházka from the Czech Centre for Phenogenomics, whose work spans functional genomics, rare genetic diseases & preclinical research.
✅ Submit your abstract
✅ Register to attend
Link: ctgct.si/en/ctgct-day...
How can a skin cell become a #StemCell capable of forming heart cells, neurons, or organoids?
Our colleague Darja Marolt Presen explored the science and challenges behind iPSC technology during a workshop with BEST Ljubljana.
Read more: ctgct.si/en/objave/ip...
#iPSC #CTGCT
Our colleague Darja Marolt Presen explored the science and challenges behind iPSC technology during a workshop with BEST Ljubljana.
Read more: ctgct.si/en/objave/ip...
#iPSC #CTGCT
From Skin Cells to Stem Cells: Reprogramming Cells to Study Disease - CTGCT
Every cell in the human body contains essentially the same genetic instructions, yet a heart cell behaves very differently from a nerve or skin cell. For many years, scientists assumed that once a cel...
ctgct.si
September 16, 2026 at 12:53 PM
How can a skin cell become a #StemCell capable of forming heart cells, neurons, or organoids?
Our colleague Darja Marolt Presen explored the science and challenges behind iPSC technology during a workshop with BEST Ljubljana.
Read more: ctgct.si/en/objave/ip...
#iPSC #CTGCT
Our colleague Darja Marolt Presen explored the science and challenges behind iPSC technology during a workshop with BEST Ljubljana.
Read more: ctgct.si/en/objave/ip...
#iPSC #CTGCT
The #CTGCTDay2026 abstract deadline has been extended to 30 September 2026.
📅11 November
📍Ljubljana
⚠️ Only 50 seats left
Link: ctgct.si/en/ctgct-day...
@kemijski.bsky.social @ucltro.bsky.social @umcutrecht.bsky.social @tudresden.bsky.social @bihatcharite.bsky.social @genehproject.bsky.social
📅11 November
📍Ljubljana
⚠️ Only 50 seats left
Link: ctgct.si/en/ctgct-day...
@kemijski.bsky.social @ucltro.bsky.social @umcutrecht.bsky.social @tudresden.bsky.social @bihatcharite.bsky.social @genehproject.bsky.social
CTGCT Day 2026: Advances in Cell, Tissue and Gene Therapy - CTGCT
CTGCT Day 2026 is a one day conference organised by the Centre of the Technologies of Gene and Cell Therapy in Ljubljana, Slovenia.
ctgct.si
September 15, 2026 at 7:01 AM
The #CTGCTDay2026 abstract deadline has been extended to 30 September 2026.
📅11 November
📍Ljubljana
⚠️ Only 50 seats left
Link: ctgct.si/en/ctgct-day...
@kemijski.bsky.social @ucltro.bsky.social @umcutrecht.bsky.social @tudresden.bsky.social @bihatcharite.bsky.social @genehproject.bsky.social
📅11 November
📍Ljubljana
⚠️ Only 50 seats left
Link: ctgct.si/en/ctgct-day...
@kemijski.bsky.social @ucltro.bsky.social @umcutrecht.bsky.social @tudresden.bsky.social @bihatcharite.bsky.social @genehproject.bsky.social
CAR-T therapy is an example of a "living medicine". How do engineered immune cells recognize and destroy cancer cells, and what challenges remain before these therapies become more widely accessible?
Read more: ctgct.si/en/objave/li...
#CART #Immunotherapy #CancerResearch
Read more: ctgct.si/en/objave/li...
#CART #Immunotherapy #CancerResearch
Living Medicines: The Promise and Challenges of CAR-T Therapy - CTGCT
Cancer treatment has undergone a remarkable transformation over the past decade. What if, instead of relying solely on drugs to attack tumors, we could reprogram a patient's own immune cells to seek o...
ctgct.si
September 10, 2026 at 1:07 PM
CAR-T therapy is an example of a "living medicine". How do engineered immune cells recognize and destroy cancer cells, and what challenges remain before these therapies become more widely accessible?
Read more: ctgct.si/en/objave/li...
#CART #Immunotherapy #CancerResearch
Read more: ctgct.si/en/objave/li...
#CART #Immunotherapy #CancerResearch
Present your research at #CTGCTDay2026!
Submit your abstract by 15 September and join confirmed speaker Petra Sušjan, Research Associate in Synthetic Biology and Immunoly department of the
@kemijski.bsky.social.
Details: ctgct.si/en/ctgct-day...
Submit your abstract by 15 September and join confirmed speaker Petra Sušjan, Research Associate in Synthetic Biology and Immunoly department of the
@kemijski.bsky.social.
Details: ctgct.si/en/ctgct-day...
September 9, 2026 at 12:25 PM
Present your research at #CTGCTDay2026!
Submit your abstract by 15 September and join confirmed speaker Petra Sušjan, Research Associate in Synthetic Biology and Immunoly department of the
@kemijski.bsky.social.
Details: ctgct.si/en/ctgct-day...
Submit your abstract by 15 September and join confirmed speaker Petra Sušjan, Research Associate in Synthetic Biology and Immunoly department of the
@kemijski.bsky.social.
Details: ctgct.si/en/ctgct-day...
David Morrow, Scientific Lead for #AdvancedTherapies at #EATRIS, is a confirmed speaker at #CTGCTDay2026!
Working in gene and cell therapy or related fields?
✅ Submit your abstract before 15th September
✅ Register to attend
Link: ctgct.si/en/ctgct-day...
#GeneAndCellTherapy
Working in gene and cell therapy or related fields?
✅ Submit your abstract before 15th September
✅ Register to attend
Link: ctgct.si/en/ctgct-day...
#GeneAndCellTherapy
September 4, 2026 at 8:41 AM
David Morrow, Scientific Lead for #AdvancedTherapies at #EATRIS, is a confirmed speaker at #CTGCTDay2026!
Working in gene and cell therapy or related fields?
✅ Submit your abstract before 15th September
✅ Register to attend
Link: ctgct.si/en/ctgct-day...
#GeneAndCellTherapy
Working in gene and cell therapy or related fields?
✅ Submit your abstract before 15th September
✅ Register to attend
Link: ctgct.si/en/ctgct-day...
#GeneAndCellTherapy
#CRISPR editors are getting more powerful. The challenge? Getting them to the right cells.
In this article, we break down the delivery technologies for CRISPR, based on the review by Tjaša Lapanja, Duško Lainšček, and colleagues.
Read more: ctgct.si/en/objave/ch...
#CTGCT @kemijski.bsky.social
In this article, we break down the delivery technologies for CRISPR, based on the review by Tjaša Lapanja, Duško Lainšček, and colleagues.
Read more: ctgct.si/en/objave/ch...
#CTGCT @kemijski.bsky.social
The Delivery Challenge of Genome Editing with CRISPR - CTGCT
In vivo delivery strategies for therapeutic CRISPRgenome editingCRISPR technologies can rewrite a disease-causing DNA sequence, switch a gene off, correct a single genetic letter or even alter gene ac...
ctgct.si
August 27, 2026 at 11:00 AM
#CRISPR editors are getting more powerful. The challenge? Getting them to the right cells.
In this article, we break down the delivery technologies for CRISPR, based on the review by Tjaša Lapanja, Duško Lainšček, and colleagues.
Read more: ctgct.si/en/objave/ch...
#CTGCT @kemijski.bsky.social
In this article, we break down the delivery technologies for CRISPR, based on the review by Tjaša Lapanja, Duško Lainšček, and colleagues.
Read more: ctgct.si/en/objave/ch...
#CTGCT @kemijski.bsky.social
We're hosting more than 30 students from across Europe at @kemijski.bsky.social, in collaboration with BEST Ljubljana
Participants are learning about CAR T therapies, iPSCs, AAV-based gene therapy, viral vector manufacturing, regulatory aspects, and the goals of #CTGCT and @genehproject.bsky.social
Participants are learning about CAR T therapies, iPSCs, AAV-based gene therapy, viral vector manufacturing, regulatory aspects, and the goals of #CTGCT and @genehproject.bsky.social
August 26, 2026 at 1:09 PM
We're hosting more than 30 students from across Europe at @kemijski.bsky.social, in collaboration with BEST Ljubljana
Participants are learning about CAR T therapies, iPSCs, AAV-based gene therapy, viral vector manufacturing, regulatory aspects, and the goals of #CTGCT and @genehproject.bsky.social
Participants are learning about CAR T therapies, iPSCs, AAV-based gene therapy, viral vector manufacturing, regulatory aspects, and the goals of #CTGCT and @genehproject.bsky.social
We're pleased to welcome Associate Professor
Duško Lainšček ( @kemijski.bsky.social ) to this year's programme.
✅ Submit your abstract
✅ Register to attend
Join the discussion: ctgct.si/en/ctgct-day...
#GeneAndCellTherapy #CTGCTDay2026 #GeneAndCellTherapy #GCT #CTGCT
Duško Lainšček ( @kemijski.bsky.social ) to this year's programme.
✅ Submit your abstract
✅ Register to attend
Join the discussion: ctgct.si/en/ctgct-day...
#GeneAndCellTherapy #CTGCTDay2026 #GeneAndCellTherapy #GCT #CTGCT
August 26, 2026 at 8:38 AM
We're pleased to welcome Associate Professor
Duško Lainšček ( @kemijski.bsky.social ) to this year's programme.
✅ Submit your abstract
✅ Register to attend
Join the discussion: ctgct.si/en/ctgct-day...
#GeneAndCellTherapy #CTGCTDay2026 #GeneAndCellTherapy #GCT #CTGCT
Duško Lainšček ( @kemijski.bsky.social ) to this year's programme.
✅ Submit your abstract
✅ Register to attend
Join the discussion: ctgct.si/en/ctgct-day...
#GeneAndCellTherapy #CTGCTDay2026 #GeneAndCellTherapy #GCT #CTGCT
📢 Registration is now open for #CTGCTDay2026
Connect with leaders from academia, clinical research, industry, and regulatory bodies discussing the next generation of cell, tissue, and gene therapies.
📍 Ljubljana, Slovenia
🎟️ Register now: ctgct.si/en/ctgct-day...
📝 Abstract deadline: 15 September
Connect with leaders from academia, clinical research, industry, and regulatory bodies discussing the next generation of cell, tissue, and gene therapies.
📍 Ljubljana, Slovenia
🎟️ Register now: ctgct.si/en/ctgct-day...
📝 Abstract deadline: 15 September
CTGCT Day 2026: Advances in Cell, Tissue and Gene Therapy - CTGCT
CTGCT Day 2026 is a one day conference organised by the Centre of the Technologies of Gene and Cell Therapy in Ljubljana, Slovenia.
ctgct.si
August 4, 2026 at 1:00 PM
📢 Registration is now open for #CTGCTDay2026
Connect with leaders from academia, clinical research, industry, and regulatory bodies discussing the next generation of cell, tissue, and gene therapies.
📍 Ljubljana, Slovenia
🎟️ Register now: ctgct.si/en/ctgct-day...
📝 Abstract deadline: 15 September
Connect with leaders from academia, clinical research, industry, and regulatory bodies discussing the next generation of cell, tissue, and gene therapies.
📍 Ljubljana, Slovenia
🎟️ Register now: ctgct.si/en/ctgct-day...
📝 Abstract deadline: 15 September
How can genome editors that exceed #AAV size limits be delivered?
Our colleagues Roman Jerala and Duško Lainšček look at #coiled-coil mediated assembly as a strategy to package genome editors in separate parts and reconstitute them in target cells.
Breakdown article: ctgct.si/en/objave/mo...
Our colleagues Roman Jerala and Duško Lainšček look at #coiled-coil mediated assembly as a strategy to package genome editors in separate parts and reconstitute them in target cells.
Breakdown article: ctgct.si/en/objave/mo...
Molecular Velcro: Using Coiled Coils to Deliver Genome Editors Beyond AAV Size Limits - CTGCT
What if one of the biggest obstacles in gene therapy could be solved by borrowing a concept from everyday life? Just as Velcro joins two separate pieces together to create a strong and functional conn...
ctgct.si
July 30, 2026 at 8:11 AM
How can genome editors that exceed #AAV size limits be delivered?
Our colleagues Roman Jerala and Duško Lainšček look at #coiled-coil mediated assembly as a strategy to package genome editors in separate parts and reconstitute them in target cells.
Breakdown article: ctgct.si/en/objave/mo...
Our colleagues Roman Jerala and Duško Lainšček look at #coiled-coil mediated assembly as a strategy to package genome editors in separate parts and reconstitute them in target cells.
Breakdown article: ctgct.si/en/objave/mo...
Interested in translating research into advanced therapies?
#CTGCT is recruiting a #GMP Production & Development Expert (PhD level) to work across GMP operations, regulatory compliance, R&D projects, and scientific dissemination.
📅Deadline: 24 Aug 2026
ctgct.si/en/jobs/
#CTGCT is recruiting a #GMP Production & Development Expert (PhD level) to work across GMP operations, regulatory compliance, R&D projects, and scientific dissemination.
📅Deadline: 24 Aug 2026
ctgct.si/en/jobs/
Job Openings - CTGCT
The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...
ctgct.si
July 27, 2026 at 7:18 AM
Interested in translating research into advanced therapies?
#CTGCT is recruiting a #GMP Production & Development Expert (PhD level) to work across GMP operations, regulatory compliance, R&D projects, and scientific dissemination.
📅Deadline: 24 Aug 2026
ctgct.si/en/jobs/
#CTGCT is recruiting a #GMP Production & Development Expert (PhD level) to work across GMP operations, regulatory compliance, R&D projects, and scientific dissemination.
📅Deadline: 24 Aug 2026
ctgct.si/en/jobs/
What does it take to turn a scientific idea into a therapy that can reach patients?
Duško Lainšček discusses genome editing, #CRISPR technologies, and the challenges of bringing gene therapies closer to the clinic in a new interview with Svet24.
ctgct.si/en/objave/du...
Duško Lainšček discusses genome editing, #CRISPR technologies, and the challenges of bringing gene therapies closer to the clinic in a new interview with Svet24.
ctgct.si/en/objave/du...
Duško Lainšček interviewed by Svet24 - CTGCT
How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient?In this interview, Duško Lainšček, researcher at the Institute of Chem...
ctgct.si
July 24, 2026 at 11:29 AM
What does it take to turn a scientific idea into a therapy that can reach patients?
Duško Lainšček discusses genome editing, #CRISPR technologies, and the challenges of bringing gene therapies closer to the clinic in a new interview with Svet24.
ctgct.si/en/objave/du...
Duško Lainšček discusses genome editing, #CRISPR technologies, and the challenges of bringing gene therapies closer to the clinic in a new interview with Svet24.
ctgct.si/en/objave/du...
📢 Call for Abstracts now open for #CTGCTDay2026
Share your research in ATMPs, manufacturing, or regulatory science and connect with experts from academia, industry, and clinical research.
📍 Ljubljana, Slovenia | 11 Nov 2026
🔗 ctgct.si/en/ctgct-day...
Share your research in ATMPs, manufacturing, or regulatory science and connect with experts from academia, industry, and clinical research.
📍 Ljubljana, Slovenia | 11 Nov 2026
🔗 ctgct.si/en/ctgct-day...
CTGCT Day 2026: Advances in Cell, Tissue and Gene Therapy - CTGCT
CTGCT Day 2026 is a one day conference organised by the Centre of the Technologies of Gene and Cell Therapy in Ljubljana, Slovenia.
ctgct.si
July 23, 2026 at 12:40 PM
📢 Call for Abstracts now open for #CTGCTDay2026
Share your research in ATMPs, manufacturing, or regulatory science and connect with experts from academia, industry, and clinical research.
📍 Ljubljana, Slovenia | 11 Nov 2026
🔗 ctgct.si/en/ctgct-day...
Share your research in ATMPs, manufacturing, or regulatory science and connect with experts from academia, industry, and clinical research.
📍 Ljubljana, Slovenia | 11 Nov 2026
🔗 ctgct.si/en/ctgct-day...
🎥 Watch: Assist. Prof. Mojca Benčina Discusses @genehproject.bsky.social and the Future of #GeneTherapy on Bloomberg Adria with Prof. Luis Pereira de Almeida
ctgct.si/en/objave/bl...
#ATMPs #EuropeanResearch #RareDiseases
ctgct.si/en/objave/bl...
#ATMPs #EuropeanResearch #RareDiseases
Bloomberg Adria Interviews Mojca Benčina on the Future of Gene Therapy and GeneH Project - CTGCT
How can Europe accelerate the journey from scientific discovery to life-changing treatments for patients with rare genetic diseases? This question was at the heart of a recent Bloomberg Adria intervie...
ctgct.si
July 21, 2026 at 11:16 AM
🎥 Watch: Assist. Prof. Mojca Benčina Discusses @genehproject.bsky.social and the Future of #GeneTherapy on Bloomberg Adria with Prof. Luis Pereira de Almeida
ctgct.si/en/objave/bl...
#ATMPs #EuropeanResearch #RareDiseases
ctgct.si/en/objave/bl...
#ATMPs #EuropeanResearch #RareDiseases
We’re excited to welcome Massimo Dominici, MD, from Università degli Studi di Modena e Reggio Emilia to #CTGCTDay2026!
He has headed the Laboratory of Cellular Therapies & co-founded biotechnology startups & research institutions.
📢Submit your abstract & join us! ctgct.si/en/ctgct-day...
He has headed the Laboratory of Cellular Therapies & co-founded biotechnology startups & research institutions.
📢Submit your abstract & join us! ctgct.si/en/ctgct-day...
July 10, 2026 at 9:05 AM
We’re excited to welcome Massimo Dominici, MD, from Università degli Studi di Modena e Reggio Emilia to #CTGCTDay2026!
He has headed the Laboratory of Cellular Therapies & co-founded biotechnology startups & research institutions.
📢Submit your abstract & join us! ctgct.si/en/ctgct-day...
He has headed the Laboratory of Cellular Therapies & co-founded biotechnology startups & research institutions.
📢Submit your abstract & join us! ctgct.si/en/ctgct-day...
#CTGCT #Newsletter No. 4 is out!
Highlights include:
🔹 #CTGCTDay2026 (11 Nov, Ljubljana) – call for contributions open
🔹 @genehproject.bsky.social &CFGBC Symposium
🔹 €15M co-financing agreement
🔹 New CAR T research (Calcium Switch)
🔹 Events, publications & job openings
👉 ctgct.si/en/objave/ct...
Highlights include:
🔹 #CTGCTDay2026 (11 Nov, Ljubljana) – call for contributions open
🔹 @genehproject.bsky.social &CFGBC Symposium
🔹 €15M co-financing agreement
🔹 New CAR T research (Calcium Switch)
🔹 Events, publications & job openings
👉 ctgct.si/en/objave/ct...
CTGCT Newsletter No. 4 - CTGCT
Just as the summer is about to start your friend and colleague the CTGCT is publishing its latest
ctgct.si
June 19, 2026 at 12:27 PM
#CTGCT #Newsletter No. 4 is out!
Highlights include:
🔹 #CTGCTDay2026 (11 Nov, Ljubljana) – call for contributions open
🔹 @genehproject.bsky.social &CFGBC Symposium
🔹 €15M co-financing agreement
🔹 New CAR T research (Calcium Switch)
🔹 Events, publications & job openings
👉 ctgct.si/en/objave/ct...
Highlights include:
🔹 #CTGCTDay2026 (11 Nov, Ljubljana) – call for contributions open
🔹 @genehproject.bsky.social &CFGBC Symposium
🔹 €15M co-financing agreement
🔹 New CAR T research (Calcium Switch)
🔹 Events, publications & job openings
👉 ctgct.si/en/objave/ct...
Inside the @genehproject.bsky.social annual meeting & the joint #GeneH & 21st CFGBC Symposium in Ljubljana (2–3 June 2026)
From functional genomics to gene therapy, discussions focused on one key goal: translating science into patient impact.
👉More: ctgct.si/en/objave/ge...
#HorizonEurope
From functional genomics to gene therapy, discussions focused on one key goal: translating science into patient impact.
👉More: ctgct.si/en/objave/ge...
#HorizonEurope
Inside the GeneH Consortium Meeting and Symposium we organised - CTGCT
On the 2nd of June 2026, the GeneH Consortium met together in Ljubljana for their yearly meeting and on the 3rd the consortium organized together with the Center for Functional Genomics and BioChips (...
ctgct.si
June 18, 2026 at 12:53 PM
Inside the @genehproject.bsky.social annual meeting & the joint #GeneH & 21st CFGBC Symposium in Ljubljana (2–3 June 2026)
From functional genomics to gene therapy, discussions focused on one key goal: translating science into patient impact.
👉More: ctgct.si/en/objave/ge...
#HorizonEurope
From functional genomics to gene therapy, discussions focused on one key goal: translating science into patient impact.
👉More: ctgct.si/en/objave/ge...
#HorizonEurope
We’re excited to welcome Zsolt Sebestyen from @umcutrecht.bsky.social to #CTGCTDay2026!
His research on tumor microenvironment & immune cells bridges science and clinical impact.
📢 Submit your abstract & join us!
ctgct.si/en/ctgct-day...
#AbstractSubmission #CellTherapy #GeneTherapy
His research on tumor microenvironment & immune cells bridges science and clinical impact.
📢 Submit your abstract & join us!
ctgct.si/en/ctgct-day...
#AbstractSubmission #CellTherapy #GeneTherapy
June 12, 2026 at 12:06 PM
We’re excited to welcome Zsolt Sebestyen from @umcutrecht.bsky.social to #CTGCTDay2026!
His research on tumor microenvironment & immune cells bridges science and clinical impact.
📢 Submit your abstract & join us!
ctgct.si/en/ctgct-day...
#AbstractSubmission #CellTherapy #GeneTherapy
His research on tumor microenvironment & immune cells bridges science and clinical impact.
📢 Submit your abstract & join us!
ctgct.si/en/ctgct-day...
#AbstractSubmission #CellTherapy #GeneTherapy
At #ASGCT2026, our colleague Duško Lainšček shared work focused on translation.
He presented:
• An #AAV9 gene therapy for #CTNNB1 syndrome
• Safety data supporting a Phase I/II trial in Slovenia
and more.
You can read it here: ctgct.si/en/objave/ct...
He presented:
• An #AAV9 gene therapy for #CTNNB1 syndrome
• Safety data supporting a Phase I/II trial in Slovenia
and more.
You can read it here: ctgct.si/en/objave/ct...
CTGCT at ASGCT 2026 - CTGCT
At the ASGCT 2026 Annual Meeting in Boston (May 11–15, 2026), held held in Boston, Massachusetts, USA, our colleague Dr. Duško Lainšček presented two pieces of work that reflect this translational rea...
ctgct.si
June 8, 2026 at 7:24 AM
At #ASGCT2026, our colleague Duško Lainšček shared work focused on translation.
He presented:
• An #AAV9 gene therapy for #CTNNB1 syndrome
• Safety data supporting a Phase I/II trial in Slovenia
and more.
You can read it here: ctgct.si/en/objave/ct...
He presented:
• An #AAV9 gene therapy for #CTNNB1 syndrome
• Safety data supporting a Phase I/II trial in Slovenia
and more.
You can read it here: ctgct.si/en/objave/ct...
The #CTGCT at @kemijski is opening two new positions to strengthen our work in quality systems and cell & gene therapy development.
1️⃣ QC Expert (Assistant with a Doctorate) Deadline: 29 June 2026
2️⃣ Assistant‑S Deadline: 1 July 2026
Link: ctgct.si/en/jobs/
#hiring #GCT #QCExpert #ResearchJobs
1️⃣ QC Expert (Assistant with a Doctorate) Deadline: 29 June 2026
2️⃣ Assistant‑S Deadline: 1 July 2026
Link: ctgct.si/en/jobs/
#hiring #GCT #QCExpert #ResearchJobs
Job Openings - CTGCT
The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...
ctgct.si
June 4, 2026 at 1:30 PM
The #CTGCT at @kemijski is opening two new positions to strengthen our work in quality systems and cell & gene therapy development.
1️⃣ QC Expert (Assistant with a Doctorate) Deadline: 29 June 2026
2️⃣ Assistant‑S Deadline: 1 July 2026
Link: ctgct.si/en/jobs/
#hiring #GCT #QCExpert #ResearchJobs
1️⃣ QC Expert (Assistant with a Doctorate) Deadline: 29 June 2026
2️⃣ Assistant‑S Deadline: 1 July 2026
Link: ctgct.si/en/jobs/
#hiring #GCT #QCExpert #ResearchJobs
Why do some tumors respond to immunotherapy while others don’t?
Join the #CTGCT #ScienceTalks with Peter Brazda from @umcutrecht.bsky.social on 3D co‑culture models and tumor–immune interactions.
1 June 2026 @ 14:00
ctgct.si/en/objave/ct...
#Immunotherapy
@kemijski.bsky.social
@ucltro.bsky.social
Join the #CTGCT #ScienceTalks with Peter Brazda from @umcutrecht.bsky.social on 3D co‑culture models and tumor–immune interactions.
1 June 2026 @ 14:00
ctgct.si/en/objave/ct...
#Immunotherapy
@kemijski.bsky.social
@ucltro.bsky.social
CTGCT Science Talks June - Assit. Prof. Peter Brazda - CTGCT
On Monday, 1st of June 2026, 2:00 PM (Ljubljana/Berlin time), Assit. Prof. Peter Brazada from the Center for Translational Immunology of the University Medical Center Utrecht , will present in our CTG...
ctgct.si
May 26, 2026 at 11:29 AM
Why do some tumors respond to immunotherapy while others don’t?
Join the #CTGCT #ScienceTalks with Peter Brazda from @umcutrecht.bsky.social on 3D co‑culture models and tumor–immune interactions.
1 June 2026 @ 14:00
ctgct.si/en/objave/ct...
#Immunotherapy
@kemijski.bsky.social
@ucltro.bsky.social
Join the #CTGCT #ScienceTalks with Peter Brazda from @umcutrecht.bsky.social on 3D co‑culture models and tumor–immune interactions.
1 June 2026 @ 14:00
ctgct.si/en/objave/ct...
#Immunotherapy
@kemijski.bsky.social
@ucltro.bsky.social
#CTGCT & @kemijski.bsky.social at BioFair 5.0
We met with students to talk careers, skills, and the future of gene & cell therapy in Slovenia.
From CTGCT’s mission to the @genehproject.bsky.social and a round table on rare genetic diseases.
ctgct.si/en/objave/ct...
We met with students to talk careers, skills, and the future of gene & cell therapy in Slovenia.
From CTGCT’s mission to the @genehproject.bsky.social and a round table on rare genetic diseases.
ctgct.si/en/objave/ct...
CTGCT at BioFair 5.0: connecting with the next generation of experts in gene and cell therapy - CTGCT
On the 13th of May, part of the CTGCT team attended BioFair 5.0 the largest career event for students in the field of life sciences in Slovenia, organized by the non-profit student association BEST Lj...
ctgct.si
May 22, 2026 at 8:36 AM
#CTGCT & @kemijski.bsky.social at BioFair 5.0
We met with students to talk careers, skills, and the future of gene & cell therapy in Slovenia.
From CTGCT’s mission to the @genehproject.bsky.social and a round table on rare genetic diseases.
ctgct.si/en/objave/ct...
We met with students to talk careers, skills, and the future of gene & cell therapy in Slovenia.
From CTGCT’s mission to the @genehproject.bsky.social and a round table on rare genetic diseases.
ctgct.si/en/objave/ct...
Next #CTGCT #ScienceTalks | 1 June, 14:00 CEST
Peter Brazda explores how 3D co‑culture models and multimodal tumor immunology workflows can unravel tumor–immune interactions—and inform next‑generation T‑cell therapies.
Read more and join the webinar: ctgct.si/en/objave/ct...
@kemijski.bsky.social
Peter Brazda explores how 3D co‑culture models and multimodal tumor immunology workflows can unravel tumor–immune interactions—and inform next‑generation T‑cell therapies.
Read more and join the webinar: ctgct.si/en/objave/ct...
@kemijski.bsky.social
CTGCT Science Talks June - Assit. Prof. Peter Brazda - CTGCT
On Monday, 1st of June 2026, 2:00 PM (Ljubljana/Berlin time), Assit. Prof. Peter Brazada from the Center for Translational Immunology of the University Medical Center Utrecht , will present in our CTG...
ctgct.si
May 15, 2026 at 1:23 PM
Next #CTGCT #ScienceTalks | 1 June, 14:00 CEST
Peter Brazda explores how 3D co‑culture models and multimodal tumor immunology workflows can unravel tumor–immune interactions—and inform next‑generation T‑cell therapies.
Read more and join the webinar: ctgct.si/en/objave/ct...
@kemijski.bsky.social
Peter Brazda explores how 3D co‑culture models and multimodal tumor immunology workflows can unravel tumor–immune interactions—and inform next‑generation T‑cell therapies.
Read more and join the webinar: ctgct.si/en/objave/ct...
@kemijski.bsky.social